Treatment strategies in adolescents with epilepsy and emerging psychosis;Terapeutiska svårigheter vid psykos hos unga patienter med epilepsi

Lakartidningen

Volumn 98, Issue 49, 2001, Pages 5661-5664

  Johansson, Björn Axel ^a   Jarbin, Håkan ^b   Lundgren, Johan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Norrlands Universitetssjukhus   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CLOZAPINE; NEUROLEPTIC AGENT;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; PSYCHOSIS; TEMPORAL LOBE EPILEPSY;

ADOLESCENT; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CHILD; CLOZAPINE; DIAGNOSIS, DIFFERENTIAL; EPILEPSY, COMPLEX PARTIAL; FEMALE; HUMANS; MALE; PSYCHOTIC DISORDERS;

EID: 0035814571     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sachdev P. Schizophrenia-like psychosis and epilepsy: The status of the association. Am J Psychiatry 1998;155:325-36.
2. Torta R, Keller R. Behavioral, psychotic and anxiety disorders in epilepsy: etiology, clinical features and therapeutic implications. Epilepsia 1999;40 Suppl 10:2-20.
3. Bredkjaer SR, Mortensen PB, Parnas J. Epilepsy and non-organic non-affective psychosis. Br J Psychiatry 1998;172:235-8.
4. Caplan R, Arbelle S, Magharious W, Guthrie D, Komo S, Shields WD, et al. Psychopathology in pediatric complex partial and primary generalized epilepsy. Dev Med Child Neurol 1998;40(12):805-11.
5. Hultman CM, Sparen P, Takei N, Murray RM, Chattingius S. Prenatal and perinatal risk factors for schizofrenia, affective psychosis and reactive psychosis of early onset: case-control study. BMJ 1999;318:421-6.
6. O'Dwyer JM. Schizophrenia in people with intellectual disability: the role of pregnancy and birth complications. J Intellect Disabil Res 1997;41(3):238-51.
7. David AS, Malmberg A, Brandt L, Allebeck P, Lewis G. IQ and risk for schizophrenia: a population-based cohort study. Psychol Med 1997; 27(6):1311-23.
8. Kirkpatrick SS, Williams DE, Matson JL, Anderson SJ. An evaluation of age and intellectual functioning on rates of psychopathology. Journal of Developmental and Physical Disabilities 1996;8(1):21-7.
9. Stevens JR. Epilepsy, schizophrenia and the extended amygdala. Ann NY Acad Sci 1999;877:548-61.
10. Matsuura M. Epileptic psychoses and anticonvulsant drug treatment. J Neurol Neurosurg Psychiatry 1999;67(2):231-3.
11. Levinson DF, Devinsky O. Psychiatric adverse events during vigabatrin therapy. Neurology 1999;53(7):1503-11.
12. Pool D, Bloom W, Mielke DH, Roniger JJ, Gallant DM. A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients. Curr Ther Res Clin Exp 1976;19:99-104.
13. Realmuto GM, Erickson WD, Yellin AM, Hopwood JH, Greenberg LM. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents. Am J Psychiatry 1984;141:440-2.
14. Campbell M, Gonzalez NM, Ernst M, Silva RR, Werry JS. Antipsychotics (Neuroleptics). In: Werry JS, Aman MG, editors. Practitioners guide to psychoactive drugs for children and adolescents. New York: Plenum; 1993. p. 269-96.
15. Meltzer H, Lee MA, Ranjan R. Recent advances in the pharmacotherapy of schizophrenia. Acta Psychiatr Scand 1994;90:95-101.
16. Campbell M, Cohen IL, Perry R, Small AM. Psychopharmacological treatment. In: Ollendick TH, Hersen M, editors. Handbook of child psychopathology. 2nd ed. New York: Plenum; 1989. p. 473-97.
17. Kumra S, Frazier JA, Jacobsen LK, McKenna K, Gordon CT, Lenane MC, et al. Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 1996;53:1090-7.
18. Remschmidt H, Hennighausen K, Clement HW, Heiser P, Schulz E. Atypical neuroleptics in child and adolescent psychiatry. Eur Child Adolesc Psychiatry 2000;9 Suppl 1:9-19.